RT001 in Progressive Supranuclear Palsy-Clinical and In-Vitro Observations.
Plamena R AngelovaKristin M AndruskaMark G MideiMario BarilaniPaldeep AtwalOliver TucherPeter MilnerFrederic HeerinckxMikhail S ShchepinovPublished in: Antioxidants (Basel, Switzerland) (2021)
MSCs derived from patients with PSP have elevated basal levels of LPO, ROS, and mitochondrial dysfunction. These findings are reversed after incubation with RT001. In PSP patients, the progression of disease may be reduced by treatment with RT001.